Nitazoxanide Shortage: What Providers and Prescribers Need to Know in 2026

Nitazoxanide (brand name Alinia) is a broad-spectrum antiparasitic and antiviral agent in the thiazolide class, FDA-approved for diarrhea caused by Giardia lamblia and Cryptosporidium parvum in immunocompetent patients. Despite its established clinical role, providers are increasingly hearing from patients who cannot locate this medication at their pharmacy. This guide covers what you need to know to prescribe effectively and counsel patients appropriately.

Current Availability Status (2026)

As of 2026, generic nitazoxanide 500 mg tablets are NOT on the FDA's official drug shortage list. However, several factors create real-world availability challenges for patients:

• Brand Alinia distribution: Brand Alinia formulations have been discontinued by some distributors. This has created confusion at the pharmacy counter where technicians search for "Alinia" and find it unavailable, even when the generic equivalent is theoretically orderable.
• Low stocking volume: Because parasitic infections represent a small fraction of prescriptions nationally, most retail pharmacies maintain zero standing stock of nitazoxanide. The drug must be ordered, which takes 24-48 hours — a meaningful delay for a patient with acute diarrheal illness.
• Oral suspension (pediatric): No FDA-approved generic exists for the Alinia oral suspension (100 mg/5 mL). Brand Alinia oral suspension availability is inconsistent. This is the most pressing availability concern for pediatric providers.

Prescribing Strategies to Maximize Successful Fills

Several prescribing practices can meaningfully reduce the chance of a patient being unable to fill their prescription:

1. Write for the generic. Always prescribe as "nitazoxanide" (generic name) with "substitution permitted" rather than "Alinia." This is the single most impactful prescribing decision you can make to improve fill rates. Generic tablets are manufactured by Rising Pharmaceuticals and available through major drug wholesalers including McKesson, AmerisourceBergen, and Cardinal Health.
2. Know your preferred pharmacy. If you regularly prescribe nitazoxanide (ID specialists, travel medicine, GI), identify 1-2 local pharmacies that stock it or can reliably order it quickly. Share this information at the point of prescribing.
3. Send to hospital outpatient pharmacies when appropriate. Hospital outpatient pharmacies associated with your institution or affiliated hospitals typically stock specialty antiparasitics. Directing patients there eliminates the 24-48 hour ordering delay.
4. For pediatric patients needing suspension: Call your hospital outpatient pharmacy or a local compounding pharmacy before prescribing to confirm availability. If unavailable, consider whether the clinical scenario supports an alternative agent or watchful waiting pending supply.

Clinical Considerations for Dosing and Use

Nitazoxanide should always be administered with food to maximize absorption — the AUC of the active metabolite tizoxanide is nearly doubled and Cmax increased by approximately 50% when taken with a meal. Ensuring patients understand this is clinically meaningful.

Standard dosing for adults and adolescents 12+: 500 mg orally every 12 hours for 3 days with food. For immunocompromised patients (including HIV), the drug has not been shown effective for C. parvum — alternative management strategies are needed.

Key drug interaction to highlight: tizoxanide (the active metabolite) is highly protein-bound (>99.9%). Caution is warranted when co-prescribing with warfarin or other drugs with narrow therapeutic indices that compete for protein binding. Avoid concurrent warfarin use; if unavoidable, monitor closely.

When to Consider Alternatives

Clinical situations where alternatives should be considered from the outset:

• Giardiasis with known formulary preference for metronidazole or tinidazole: Tinidazole 2 g PO once is highly efficacious, inexpensive, and widely available. It is a reasonable first choice when availability or cost are concerns.
• Cryptosporidiosis in immunocompromised patients: Nitazoxanide is not recommended. Focus on immune restoration (antiretroviral therapy for HIV patients) and supportive care. Paromomycin has some activity and may be used as adjunct therapy.
• Pregnancy: Data on nitazoxanide in pregnancy is limited. Paromomycin (minimally absorbed) is often preferred for protozoal infections in pregnancy when treatment is necessary.
• Hypersensitivity to nitazoxanide: Absolute contraindication. Metronidazole or tinidazole are the primary alternatives for Giardia; paromomycin for Cryptosporidium.

How to Counsel Patients on Finding Their Prescription

Patients prescribed nitazoxanide should be counseled that it may not be immediately available at every pharmacy and given the following guidance: (1) ask specifically for 'nitazoxanide 500 mg tablets'; (2) call hospital outpatient pharmacies first; (3) use medfinder to have pharmacies contacted on their behalf. You can also point patients to our guide on finding nitazoxanide in stock for step-by-step instructions.

Cost Considerations for Patients

Nitazoxanide pricing varies dramatically depending on brand vs. generic and discount tool use. Brand Alinia can retail at $1,350-$1,605 per 6-tablet prescription. Generic nitazoxanide retails at $833-$1,113, but GoodRx coupons reduce this to approximately $223. For commercially insured patients on brand Alinia, Romark offers a co-pay card that can reduce out-of-pocket cost to $0 (visit alinia.com/savings/tablets). Most insurance plans place generic nitazoxanide at Tier 1-2 with $0-$30 copays.

Recommending the generic at point of prescribing (writing "nitazoxanide" with "substitution permitted") is the most impactful single step for reducing patient cost and improving fill rates.

Summary for Providers

• No FDA-declared shortage for generic nitazoxanide tablets in 2026
• Brand Alinia discontinued by some distributors; no generic for oral suspension
• Prescribe generically with substitution permitted; direct to hospital outpatient pharmacies
• Counsel patients: always take with food; avoid warfarin co-use when possible
• Alternatives: tinidazole/metronidazole for Giardia; paromomycin for Cryptosporidium in pregnancy/immunocompromised